P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

June 2010

Features

Health Care and Law

New Court Ruling May Alter the Legal Landscape for Gene Patents

A closely watched legal decision raises the question of whether companies will be able to protect their ownership of genetic information.
Robert I. Field, JD, MPH, PhD

Drug Review

Oxymorphone Extended-Release Tablets (Opana ER) For the Management of Chronic Pain

A Practical Review for Pharmacists

Dr. Craig describes the drug’s pharmacology, pharmacokinetics, efficacy, and safety; the process of switching from other agents; and ways ­pharmacists can help prevent abuse of this controlled substance.
David S. Craig, PharmD, BCPS

Meeting Highlights

American Academy of Neurology, 62nd Annual Meeting and American Society of Hypertension, 25th Annual Scientific Meeting and Exposition

Neurology topics include Guillain-Barré syndrome after H1N1 vaccine administration, sodium oxybate for fibromyalgia, and botulinum neurotoxin type A (NT-201) for dystonias. Angiotensin-receptor blocker combinations for hypertension include phentermine/topiramate, amlodipine/olmesartan, and chlorthalidone/azilsartan.
Walter Alexander

Pharmaceutical Approval Update

Sipuleucel-T (Provenge) for prostate cancer, polidocanol (Asclera) for varicose veins, and imiquimod cream 3.75% (Zyclara) for actinic keratoses are discussed.
Marvin M. Goldenberg, PhD, RPh, MS

Continuing Education Credit

Seborrheic Dermatitis

A chronic inflammation of the skin, seborrheic dermatitis affects more than 11% of people and almost 70% of infants. The authors discuss various drug and non-drug therapies and the role of the pharmacist in counseling patients about this condition and its treatment.
Thomas Berk, MD, and Noah Scheinfeld, MD

Departments

Editorial

Interdependence

A former American President has inspired our editor-in-chief to reflect on our global economy and interdependence.
David B. Nash, MD, MBA

Medication Errors

Transforming the Culture of Patient Safety in Organizations

Preventing catastrophic events requires transforming the culture of patient safety.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

FDA’s New Guidelines on Serialized Numerical Identifiers Are Not Helpful to Pharmacies

Stephen Barlas explains why many pharmacists are not being helped by the FDA’s ­latest guidance on authenticating drug packages.
Stephen Barlas

New Drugs/Drug News/New Medical Devices

P&T presents FDA approvals, drug indications, product recalls, and devices in the news.

Drug Forecast

Role of Tapentadol Immediate Release (Nucynta) in the Management of Moderate-to-Severe Pain

Immediate-release tapentadol (Nucynta) for moderate-to-severe pain is discussed.
Bazhena Fidman, PharmD Candidate, and Anna Nogid, BS, PharmD, BCPS